Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy.

JACC. Cardiovascular interventions

Volumn 6, Issue 2, 2013, Pages 182-184

  Ferreiro, José Luis ^a   Ueno, Masafumi ^b   Tello Montoliu, Antonio ^b   Tomasello, Salvatore D ^b   Seecheran, Naveen ^b   Desai, Bhaloo ^b   Rollini, Fabiana ^b   Guzman, Luis A ^b   Bass, Theodore A ^b   Angiolillo, Dominick J ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; DIAGNOSTIC AGENT; P2RY12 PROTEIN, HUMAN; PHOSPHOPROTEIN; PIPERAZINE DERIVATIVE; PRASUGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR; THIOPHENE DERIVATIVE; VASODILATOR STIMULATED PHOSPHOPROTEIN; VASODILATOR-STIMULATED PHOSPHOPROTEIN;

ACUTE CORONARY SYNDROME; ARTICLE; BLOOD; BLOOD CLOTTING PARAMETERS; CHI SQUARE DISTRIBUTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFECT; DRUG RESISTANCE; HUMAN; METABOLISM; PERCUTANEOUS CORONARY INTERVENTION; PHOSPHORYLATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; TIME; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADENOSINE DIPHOSPHATE; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL ADHESION MOLECULES; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; HUMANS; MICROFILAMENT PROTEINS; PERCUTANEOUS CORONARY INTERVENTION; PHOSPHOPROTEINS; PHOSPHORYLATION; PIPERAZINES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; THIOPHENES; TIME FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84881284041     PISSN: None     EISSN: 18767605     Source Type: None    
DOI: 10.1016/j.jcin.2012.10.007     Document Type: Article

References (0)